Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis

Journal of the American Society of Nephrology

Volumn 12, Issue 1, 2001, Pages 143-150

  Candiano, G ^a   Musante, L ^a   Carraro, M ^a   Faccini, L ^a   Campanacci, L ^a   Zennaro, C ^a   Artero, M ^a   Ginevri, F ^a   Perfumo, F ^a   Gusmano, R ^a   Ghiggeri, G M ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN; APOLIPOPROTEIN A4; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEIN L; CLUSTERIN; HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULONEPHRITIS; HUMAN; KIDNEY FAILURE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT;

EID: 0035163170     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Prediction and treatment of focal segmental glomerulosclerosis after renal transplantation in children
2. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis
3. Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange
4. Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome
5. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
6. A new method of measuring albumin permeability in isolated glomeruli
7. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome
8. "The FSGS factor": Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
9. Measurement of albumin reflection coefficient using isolated rat glomeruli
10. 1-dicycloherylcarbodinide-binding proteolipid, active in proton translocation
11. A non-linear wide-range immobilized pH gradient for two-dimensional electrophoresis and its identification in a relevant pH scale
12. Resolution of fibronectin and other uncharacterized proteins by two dimensional polyacrylamide electrophoresis with thiourea
13. Negative staining of proteins in polyacrylamide gels with methyl trichloroacetate
14. Copper staining: A five minute protein stain for sodium dodecyl sulfate-polyacrylamide gels
15. Elution of proteins from sodium dodecyl sulfate and renaturation of enzymatic activity: Results with Sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase and other enzymes
16. Identification of two dimensional gel electrophoresis resolved yeast proteins by matrix-assisted laser desorption ionization mass spectrometry
17. Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma
18. HDL particle associated proteins in plasma and cerebrospinal fluid: Identification and partial sequencing
19. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
20. Characterization of a human high density lipoprotein-associated protein, NA1/NA2: Identity with SP-40,40, an inhibitor of complement-mediated cytolysis
21. Apolipoprotein multigene family: Tandem organization of human apolipoprotein A-I, C-III and A-IV genes
22. Apolipoprotein L, a new high density lipoprotein apolipoprotein expressed by the pancreas
23. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: A link between the complement and reproductive systems
24. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene
25. Clinical application of high-resolution two-dimensional polyacrylamide gel electrophoresis
26. Plasma metabolism of apolipoprotein A-IV in humans
27. Type III hyperlipoproteinemia: Diagnosis in whole plasma by apolipoprotein E immunoassay
28. Serum and urinary high density lipoprotein in glomerular disease with proteinuria
29. Renal apolipoprotein in nephrotic rats
30. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM
31. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
32. Polymorphism of the apolipoprotein A-IV gene and its significance in lipid metabolism and coronary heart disease in a Japanese population
33. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis
34. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM
35. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy
36. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients
37. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology